ISPOR 2026
Sunday, May 17 - Wednesday, May 20
-
DECISION MODEL EVALUATING CLINICAL EVENT-RELATED COSTS OF PERSISTING WITH APIXABAN COMPARED WITH SWITCHING TO RIVAROXABAN AFTER A BLEEDING EVENT IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION IN THE UNITED STATES
Mar 18, 2026, 21:38 PM -
NEUROLOGIST PREFERENCES FOR NEW MS TREATMENTS: IMPLICATIONS FOR MARKET ACCESS PRIORITIZATION IN THE UNITED STATES AND EUROPE
Mar 18, 2026, 21:38 PM -
IDENTIFYING DRUG REPURPOSING OPPORTUNITIES WITH AI THROUGH LITERATURE REVIEW: A STRUCTURED APPROACH FOR DETECTING NOVEL THERAPEUTIC SIGNALS IN PUBLISHED STUDIES
Mar 18, 2026, 21:38 PM -
LEVERAGING ARTIFICIAL INTELLIGENCE TO EXPEDITE DOSSIER DEVELOPMENT: A SYSTEMATIC LITERATURE REVIEW
Mar 18, 2026, 21:38 PM -
COST OF 5-YEAR PROGRESSION FREE SURVIVAL ANALYSIS OF TRIPLE-CLASS EXPOSED PATIENTS WITH REFRACTORY/RELAPSED MULTIPLE MYELOMA TREATED WITH CILTACABTAGENE AUTOLEUCEL IN THE BRAZILIAN PRIVATE HEALTH SYSTEM
Mar 18, 2026, 21:38 PM -
NATURAL HISTORY, MANAGEMENT, AND BURDEN OF DISEASE IN ADULTS WITH NF1 AND SYMPTOMATIC INOPERABLE PLEXIFORM NEUROFIBROMA IN FRANCE
Mar 18, 2026, 21:38 PM -
UPTAKE OF BIOSIMILARS TO INSULIN GLARGINE IN 2021-2025 IN THE UNITED STATES
Mar 18, 2026, 21:38 PM -
USE ARTIFICIAL INTELLIGENCE TO PREDICT REGULATORY APPROVAL BASED ON PHASE III ONCOLOGY CLINICAL TRIAL PUBLICATIONS
Mar 18, 2026, 21:38 PM -
ENHANCING TRANSFUSION MEDICINE EFFICIENCY THROUGH NAT SYSTEM TECHNOLOGY INNOVATION
Mar 18, 2026, 21:38 PM -
COST-EFFECTIVENESS OF ELRANATAMAB VERSUS PHYSICIAN’S CHOICE OF TREATMENT FOR TRIPLE-CLASS-EXPOSED MULTIPLE MYELOMA IN JAPAN
Mar 18, 2026, 21:38 PM -
HEALTH AND ECONOMIC EFFECTS OF RECOMBINANT ZOSTER VACCINATION AMONG UNINSURED ADULTS IN THE UNITED STATES USING ALTERNATIVE VALUATION METHODS
Mar 18, 2026, 21:38 PM -
REAL-WORLD USE OF GENERATIVE AI ASSISTANT TOOLS ACROSS HEALTH ECONOMICS AND OUTCOMES RESEARCH WORKFLOWS: A SCOPING REVIEW
Mar 18, 2026, 21:38 PM -
EMERGING PATTERNS OF GLP-1 MICRODOSING IN A LARGE REAL-WORLD POPULATION
Mar 18, 2026, 21:38 PM -
NATIONWIDE COVID-19 TESTING PATTERNS AND DISPARITIES IN POSITIVITY AND ANTIVIRAL TREATMENT IN A U.S. RETAIL PHARMACY CHAIN, SEPTEMBER-DECEMBER 2025
Mar 18, 2026, 21:38 PM -
DIGITAL CAREGIVER TRAINING FOR PROMOTING FUNCTIONAL INDEPENDENCE AND HEALTHY AGING
Mar 18, 2026, 21:38 PM -
REAL-WORLD COMPARISON OF OLANZAPINE/SAMIDORPHAN VS OLANZAPINE: AN ASSESSMENT OF TREATMENT PATTERNS AND ACUTE CARE EVENTS AMONG PATIENTS WITH SCHIZOPHRENIA OR BIPOLAR I DISORDER
Mar 18, 2026, 21:38 PM -
REAL-WORLD TREATMENT PATTERNS AND HOSPITALIZATION FREQUENCY OF ASTHMA IN THE BRAZILIAN PUBLIC HEALTH SYSTEM
Mar 18, 2026, 21:38 PM -
UNCOVERING EVIDENCE GAPS IN THE CLINICAL, ECONOMIC, AND HUMANISTIC IMPACT OF DUCHENNE MUSCULAR DYSTROPHY: A COMPREHENSIVE LITERATURE REVIEW
Mar 18, 2026, 21:38 PM -
TERMINAL CARE COSTS IN JAPAN USING LINKED HEALTH AND LONG-TERM CARE CLAIMS: WHICH IS MORE EXPENSIVE—HOSPITAL DEATH OR LONG-TERM CARE FACILITY DEATH?
Mar 18, 2026, 21:38 PM -
INDIVIDUAL PREFERENCES FOR UPPER EXTREMITY PROSTHETICS ALONG A USER-COMPLEXITY FRAMEWORK: A DISCRETE CHOICE EXPERIMENT
Mar 18, 2026, 21:38 PM